GRAL:BMV
Grail Inc
MX$1,601.00
0.00%
(0.00) 1D
Sep 21, 9:28:07 AM GMT-6 · MXN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GRAL...
Mkt. cap
6.28B
Avg. vol.
26.00
Volume
0.00
52-wk high
MX$1,828.00
52-wk low
MX$825.00
No. of employees
910
Mkt. cap
6.28B
Avg. vol.
26.00
Volume
0.00
52-wk high
MX$1,828.00
52-wk low
MX$825.00
No. of employees
910
News stories
From web sources and news partners
Insider Monkey
·
1 day ago
Grail (GRAL) vs Guardant Health (GH): Which is a Better Stock to Buy?
Simply Wall Street
·
3 days ago
GRAIL (GRAL) Unveils New Galleri Data, Is The Stock 41% Overvalued?
Profile
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021, GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023, EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.
Joshua Ofman is CEO. Wikipedia
About Grail Inc
CEO-
Employees910
Founded2015
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegrail.com